Tissue Engineered Myocardium

Studies in Mechanobiology, Tissue Engineering and Biomaterials

Volumn 6, Issue , 2011, Pages 111-132

  Zimmermann, Wolfram Hubertus ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Cardiac Specification; Cell Sheet; Hypoplastic Left Heart Syndrome; Stem Cell Technology; Tissue Engineering

Indexed keywords

EID: 85055177667     PISSN: 18682006     EISSN: 18682014     Source Type: Book Series    
DOI: 10.1007/8415_2010_41     Document Type: Chapter

References (114)

1. Cohen, S., Leor, J.: Rebuilding broken hearts. Biologists and engineers working together in the fledgling field of tissue engineering are within reach of one of their greatest goals: Constructing a living human heart patch. Sci. Am. 291(5), 44–51 (2004)
2. Khademhosseini, A., Vacanti, J.P., Langer, R.: Progress in tissue engineering. Sci. Am. 300(5), 64–71 (2009)
3. Zimmermann, W.H., Melnychenko, I., Eschenhagen, T.: Engineered heart tissue for regeneration of diseased hearts. Biomaterials 25(9), 1639–1647 (2004)
4. Eschenhagen, T., Zimmermann, W.H.: Engineering myocardial tissue. Circ. Res. 97(12), 1220–1231 (2005)
5. Jawad, H., Lyon, A.R., Harding, S.E., Ali, N.N., Boccaccini, A.R.: Myocardial tissue engineering. Br. Med. Bull. 87, 31–47 (2008)
6. Zimmermann, W.H.: Remuscularizing failing hearts with tissue engineered myocardium. Antioxid. Redox Signal. 11(8), 2011–2023 (2009)
7. Burrows, M.T.: Rhythmical activity of isolated heart muscle cells in vitro. Science 36(916), 90–92 (1912)
8. Moscona, A.: Rotation-mediated histogenetic aggregation of dissociated cells. A quantifiable approach to cell interactions in vitro. Exp. Cell Res. 22, 455–475 (1961)
9. Sperelakis, N.: Cultured heart cell reaggregate model for studying cardiac toxicology. Environ. Health Perspect. 26, 243–267 (1978)
10. Kelm, J.M., Ehler, E., Nielsen, L.K., Schlatter, S., Perriard, J.C., Fussenegger, M.: Design of artificial myocardial microtissues. Tissue Eng. 10(1–2), 201–214 (2004)
11. Zimmermann, W.H., Eschenhagen, T.: Cardiac tissue engineering for replacement therapy. Heart Fail Rev. 8(3), 259–269 (2003)
12. Shimizu, T., Yamato, M., Isoi, Y., Akutsu, T., Setomaru, T., Abe, K., Kikuchi, A., Umezu, M., Okano, T.: Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ. Res. 90(3), e40 (2002)
13. Ott, H.C., Matthiesen, T.S., Goh, S.K., Black, L.D., Kren, S.M., Netoff, T.I., Taylor, D.A.: Perfusion-decellularized matrix: Using nature’s platform to engineer a bioartificial heart. Nat. Med. 14(2), 213–221 (2008)
14. Shimizu, T., Sekine, H., Yang, J., Isoi, Y., Yamato, M., Kikuchi, A., Kobayashi, E., Okano, T.: Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues. FASEB J. 20(6), 708–710 (2006)
15. Morritt, A.N., Bortolotto, S.K., Dilley, R.J., Han, X., Kompa, A.R., McCombe, D., Wright, C.E., Itescu, S., Angus, J.A., Morrison, W.A.: Cardiac tissue engineering in an in vivo vascularized chamber. Circulation 115(3), 353–360 (2007)
16. Langer, R., Vacanti, J.P.: Tissue engineering. Science 260(5110), 920–926 (1993)
17. Bursac, N., Papadaki, M., Cohen, R.J., Schoen, F.J., Eisenberg, S.R., Carrier, R., Vunjak-Novakovic, G., Freed, L.E.: Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Am. J. Physiol. 277(2 Pt 2), H433–H444 (1999)
18. Carrier, R.L., Papadaki, M., Rupnick, M., Schoen, F.J., Bursac, N., Langer, R., Freed, L.E., Vunjak-Novakovic, G.: Cardiac tissue engineering: Cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol. Bioeng. 64(5), 580–589 (1999)
19. Leor, J., Aboulafia-Etzion, S., Dar, A., Shapiro, L., Barbash, I.M., Battler, A., Granot, Y., Cohen, S.: Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation 102(19 Suppl 3), III56–III61 (2000)
20. Sakai, T., Li, R.K., Weisel, R.D., Mickle, D.A., Kim, E.T., Jia, Z.Q., Yau, T.M.: The fate of a tissue-engineered cardiac graft in the right ventricular outflow tract of the rat. J. Thorac. Cardiovasc. Surg. 121(5), 932–942 (2001)
21. Kofidis, T., Akhyari, P., Boublik, J., Theodorou, P., Martin, U., Ruhparwar, A., Fischer, S., Eschenhagen, T., Kubis, H.P., Kraft, T., Leyh, R., Haverich, A.: In vitro engineering of heart muscle: Artificial myocardial tissue. J. Thorac. Cardiovasc. Surg. 124(1), 63–69 (2002)
22. van Luyn, M.J., Tio, R.A., Gallego y van Seijen, X.J., Plantinga, J.A., de Leij, L.F., DeJongste, M.J., van Wachem, P.B.: Cardiac tissue engineering: characteristics of in unison contracting two-and three-dimensional neonatal rat ventricle cell (co)-cultures. Biomaterials 23(24), 4793–4801 (2002)
23. Radisic, M., Park, H., Shing, H., Consi, T., Schoen, F.J., Langer, R., Freed, L.E., Vunjak-Novakovic, G.: Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc. Natl. Acad. Sci. USA 101(52), 18129–18134 (2004)
24. Caspi, O., Lesman, A., Basevitch, Y., Gepstein, A., Arbel, G., Habib, I.H., Gepstein, L., Levenberg, S.: Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ. Res. 100(2), 263–272 (2007)
25. Engelmayr Jr., G.C., Cheng, M., Bettinger, C.J., Borenstein, J.T., Langer, R., Freed, L.E.: Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nat. Mater. 7(12), 1003–1010 (2008)
26. Zimmermann, W.H., Schneiderbanger, K., Schubert, P., Didie, M., Munzel, F., Heubach, J.F., Kostin, S., Neuhuber, W.L., Eschenhagen, T.: Tissue engineering of a differentiated cardiac muscle construct. Circ. Res. 90(2), 223–230 (2002)
27. Eschenhagen, T., Fink, C., Remmers, U., Scholz, H., Wattchow, J., Weil, J., Zimmermann, W., Dohmen, H.H., Schafer, H., Bishopric, N., Wakatsuki, T., Elson, E.L.: Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: A new heart muscle model system. FASEB J. 11(8), 683–694 (1997)
28. Zimmermann, W.H., Fink, C., Kralisch, D., Remmers, U., Weil, J., Eschenhagen, T.: Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol. Bioeng. 68(1), 106–114 (2000)
29. Birla, R.K., Borschel, G.H., Dennis, R.G., Brown, D.L.: Myocardial engineering in vivo: Formation and characterization of contractile, vascularized three-dimensional cardiac tissue. Tissue Eng. 11(5–6), 803–813 (2005)
30. Bakunts, K., Gillum, N., Karabekian, Z., Sarvazyan, N.: Formation of cardiac fibers in matrigel matrix. Biotechniques 44(3), 341–348 (2008)
31. Baar, K., Birla, R., Boluyt, M.O., Borschel, G.H., Arruda, E.M., Dennis, R.G.: Self-organization of rat cardiac cells into contractile 3-d cardiac tissue. FASEB J. 19(2), 275–277 (2005)
32. Huang, Y.C., Khait, L., Birla, R.K.: Contractile three-dimensional bioengineered heart muscle for myocardial regeneration. J. Biomed. Mater. Res. A 80(3), 719–731 (2007)
33. Haraguchi, Y., Shimizu, T., Yamato, M., Kikuchi, A., Okano, T.: Electrical coupling of cardiomyocyte sheets occurs rapidly via functional gap junction formation. Biomaterials 27(27), 4765–4774 (2006)
34. Schmidt, C.E., Baier, J.M.: Acellular vascular tissues: Natural biomaterials for tissue repair and tissue engineering. Biomaterials 21(22), 2215–2231 (2000)
35. Korecky, B., Hai, C.M., Rakusan, K.: Functional capillary density in normal and transplanted rat hearts. Can. J. Physiol. Pharmacol. 60(1), 23–32 (1982)
36. Kofidis, T., Lebl, D.R., Martinez, E.C., Hoyt, G., Tanaka, M., Robbins, R.C.: Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation 112(9 Suppl), I173–I177 (2005)
37. Landa, N., Miller, L., Feinberg, M.S., Holbova, R., Shachar, M., Freeman, I., Cohen, S., Leor, J.: Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation 117(11), 1388–1396 (2008)
38. Leor, J., Tuvia, S., Guetta, V., Manczur, F., Castel, D., Willenz, U., Petnehazy, O., Landa, N., Feinberg, M.S., Konen, E., Goitein, O., Tsur-Gang, O., Shaul, M., Klapper, L., Cohen, S.: Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in swine. J. Am. Coll. Cardiol. 54(11), 1014–1023 (2009)
39. Radisic, M., Park, H., Gerecht, S., Cannizzaro, C., Langer, R., Vunjak-Novakovic, G.: Biomimetic approach to cardiac tissue engineering. Philos. Trans. R. Soc. Lond. B Biol. Sci. 362(1484), 1357–1368 (2007)
40. Zak, R.: Development and proliferative capacity of cardiac muscle cells. Circ. Res. 35((2) suppl II), 17–26 (1974)
41. Nag, A.C., Zak, R.: Dissociation of adult mammalian heart into single cell suspension: An ultrastructural study. J. Anat. 129(Pt 3), 541–559 (1979)
42. Naito, H., Melnychenko, I., Didie, M., Schneiderbanger, K., Schubert, P., Rosenkranz, S., Eschenhagen, T., Zimmermann, W.H.: Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation 114(1 Suppl), I72–I78 (2006)
43. Banerjee, I., Fuseler, J.W., Price, R.L., Borg, T.K., Baudino, T.A.: Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. Am. J. Physiol. Heart Circ. Physiol. 293(3), H1883–H1891 (2007)
44. Radisic, M., Park, H., Martens, T.P., Salazar-Lazaro, J.E., Geng, W., Wang, Y., Langer, R., Freed, L.E., Vunjak-Novakovic, G.: Pre-treatment of synthetic elastomeric scaffolds by cardiac fibroblasts improves engineered heart tissue. J. Biomed. Mater. Res. A 86(3), 713–724 (2008)
45. Kakkar, R., Lee, R.T.: Intramyocardial fibroblast myocyte communication. Circ. Res. 106(1), 47–57 (2010)
46. Ieda, M., Tsuchihashi, T., Ivey, K.N., Ross, R.S., Hong, T.T., Shaw, R.M., Srivastava, D.: Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling. Dev. Cell. 16(2), 233–244 (2009)
47. Souders, C.A., Bowers, S.L., Baudino, T.A.: Cardiac fibroblast: the renaissance cell. Circ. Res. 105(12), 1164–1176 (2009)
48. Sekine, H., Shimizu, T., Hobo, K., Sekiya, S., Yang, J., Yamato, M., Kurosawa, H., Kobayashi, E., Okano, T.: Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts. Circulation 118(14 Suppl), S145–S152 (2008)
49. Moldovan, N.I., Goldschmidt-Clermont, P.J., Parker-Thornburg, J., Shapiro, S.D., Kolattukudy, P.E.: Contribution of monocytes/macrophages to compensatory neovascularization: The drilling of metalloelastase-positive tunnels in ischemic myocardium. Circ. Res. 87(5), 378–384 (2000)
50. Leor, J., Rozen, L., Zuloff-Shani, A., Feinberg, M.S., Amsalem, Y., Barbash, I.M., Kachel, E., Holbova, R., Mardor, Y., Daniels, D., Ocherashvilli, A., Orenstein, A., Danon, D.: Ex vivo activated human macrophages improve healing, remodeling, and function of the infarcted heart. Circulation 114(1 Suppl), I94–I100 (2006)
51. Ieda, M., Kanazawa, H., Kimura, K., Hattori, F., Ieda, Y., Taniguchi, M., Lee, J.K., Matsumura, K., Tomita, Y., Miyoshi, S., Shimoda, K., Makino, S., Sano, M., Kodama, I., Ogawa, S., Fukuda, K.: Sema3a maintains normal heart rhythm through sympathetic innervation patterning. Nat. Med. 13(5), 604–612 (2007)
52. Ieda, M., Fukuda, K.: New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: The regulatory mechanisms of cardiac innervation and their critical roles in cardiac performance. J. Pharmacol. Sci. 109(3), 348–353 (2009)
53. Bowers, S.L., Banerjee, I., Baudino, T.A.: The extracellular matrix: at the center of it all. J. Mol. Cell. Cardiol. 48(3), 474–482 (2010)
54. Michel, J.B.: Anoikis in the cardiovascular system: Known and unknown extracellular mediators. Arterioscler Thromb. Vasc. Biol. 23(12), 2146–2154 (2003)
55. Corda, S., Samuel, J.L., Rappaport, L.: Extracellular matrix and growth factors during heart growth. Heart Fail Rev. 5(2), 119–130 (2000)
56. Barczyk, M., Carracedo, S., Gullberg, D.: Integrins. Cell Tissue Res. 339(1), 269–280
57. Ross, R.S., Borg, T.K.: Integrins and the myocardium. Circ. Res. 88(11), 1112–1119 (2001)
58. von der Mark, K., Park, J., Bauer, S., Schmuki, P.: Nanoscale engineering of biomimetic surfaces: Cues from the extracellular matrix. Cell Tissue Res. 339(1), 131–153 (2010)
59. Fassler, R., Rohwedel, J., Maltsev, V., Bloch, W., Lentini, S., Guan, K., Gullberg, D., Hescheler, J., Addicks, K., Wobus, A.M.: Differentiation and integrity of cardiac muscle cells are impaired in the absence of beta 1 integrin. J. Cell Sci. 109(Pt 13), 2989–2999 (1996)
60. Manner, J., Wessel, A., Yelbuz, T.M.: How does the tubular embryonic heart work? Looking for the physical mechanism generating unidirectional blood flow in the valveless embryonic heart tube. Dev. Dyn. 239(4), 1035–1046 (2010)
61. Opie, L.H., Commerford, P.J., Gersh, B.J., Pfeffer, M.A.: Controversies in ventricular remodelling. Lancet 367(9507), 356–367 (2006)
62. Keller, B.B., Liu, L.J., Tinney, J.P., Tobita, K.: Cardiovascular developmental insights from embryos. Ann. N. Y. Acad. Sci. 1101, 377–388 (2007)
63. Depre, C., Shipley, G.L., Chen, W., Han, Q., Doenst, T., Moore, M.L., Stepkowski, S., Davies, P.J., Taegtmeyer, H.: Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nat. Med. 4(11), 1269–1275 (1998)
64. Korte, F.S., Herron, T.J., Rovetto, M.J., McDonald, K.S.: Power output is linearly related to myhc content in rat skinned myocytes and isolated working hearts. Am. J. Physiol. Heart Circ. Physiol. 289(2), H801–H812 (2005)
65. Fink, C., Ergun, S., Kralisch, D., Remmers, U., Weil, J., Eschenhagen, T.: Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. FASEB J. 14(5), 669–679 (2000)
66. Zimmermann, W.H., Melnychenko, I., Wasmeier, G., Didie, M., Naito, H., Nixdorff, U., Hess, A., Budinsky, L., Brune, K., Michaelis, B., Dhein, S., Schwoerer, A., Ehmke, H., Eschenhagen, T.: Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat. Med. 12(4), 452–458 (2006)
67. Radisic, M., Park, H., Chen, F., Salazar-Lazzaro, J.E., Wang, Y., Dennis, R., Langer, R., Freed, L.E., Vunjak-Novakovic, G.: Biomimetic approach to cardiac tissue engineering: Oxygen carriers and channeled scaffolds. Tissue Eng. 12(8), 2077–2091 (2006)
68. Radisic, M., Marsano, A., Maidhof, R., Wang, Y., Vunjak-Novakovic, G.: Cardiac tissue engineering using perfusion bioreactor systems. Nat. Protoc. 3(4), 719–738 (2008)
69. Katschinski, D.M.: In vivo functions of the prolyl-4-hydroxylase domain oxygen sensors: Direct route to the treatment of anaemia and the protection of ischaemic tissues. Acta Physiol. (Oxf) 195(4), 407–414 (2009)
70. Radisic, M., Deen, W., Langer, R., Vunjak-Novakovic, G.: Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am. J. Physiol. Heart Circ. Physiol. 288(3), H1278–H1289 (2005)
71. Radisic, M., Malda, J., Epping, E., Geng, W., Langer, R., Vunjak-Novakovic, G.: Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol. Bioeng. 93(2), 332–343 (2006)
72. Zimmermann, W.H., Didie, M., Wasmeier, G.H., Nixdorff, U., Hess, A., Melnychenko, I., Boy, O., Neuhuber, W.L., Weyand, M., Eschenhagen, T.: Cardiac grafting of engineered heart tissue in syngenic rats. Circulation 106(12 Suppl 1), I151–I157 (2002)
73. Kattman, S.J., Adler, E.D., Keller, G.M.: Specification of multipotential cardiovascular progenitor cells during embryonic stem cell differentiation and embryonic development. Trends Cardiovasc. Med. 17(7), 240–246 (2007)
74. Guo, X.M., Zhao, Y.S., Chang, H.X., Wang CY, E.L.L., Zhang, X.A., Duan, C.M., Dong, L.Z., Jiang, H., Li, J., Song, Y., Yang, X.J.: Creation of engineered cardiac tissue in vitro from mouse embryonic stem cells. Circulation 113(18), 2229–2237 (2006)
75. Peerani, R., Zandstra, P.W.: Enabling stem cell therapies through synthetic stem cell-niche engineering. J. Clin. Invest. 120(1), 60–70 (2010)
76. Mummery, C., Ward-van Oostwaard, D., Doevendans, P., Spijker, R., van den Brink, S., Hassink, R., van der Heyden, M., Opthof, T., Pera, M., de la Riviere, A.B., Passier, R., Tertoolen, L.: Differentiation of human embryonic stem cells to cardiomyocytes: Role of coculture with visceral endoderm-like cells. Circulation 107(21), 2733–2740 (2003)
77. Kattman, S.J., Huber, T.L., Keller, G.M.: Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev. Cell 11(5), 723–732 (2006)
78. Yang, L., Soonpaa, M.H., Adler, E.D., Roepke, T.K., Kattman, S.J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G.W., Linden, R.M., Field, L.J., Keller, G.M.: Human cardiovascular progenitor cells develop from a kdr+ embryonic-stem-cell-derived population. Nature 453(7194), 524–528 (2008)
79. Bhana, B., Iyer, R.K., Chen, W.L., Zhao, R., Sider, K.L., Likhitpanichkul, M., Simmons, C.A., Radisic, M.: Influence of substrate stiffness on the phenotype of heart cells. Biotechnol. Bioeng. 105(6), 1148–1160 (2010)
80. Engler, A.J., Sen, S., Sweeney, H.L., Discher, D.E.: Matrix elasticity directs stem cell lineage specification. Cell 126(4), 677–689 (2006)
81. Song, H., Yoon, C., Kattman, S.J., Dengler, J., Masse, S., Thavaratnam, T., Gewarges, M., Nanthakumar, K., Rubart, M., Keller, G.M., Radisic, M., Zandstra, P.W.: Interrogating functional integration between injected pluripotent stem cell-derived cells and surrogate cardiac tissue. Proc. Natl. Acad. Sci. USA 107(8), 3329–3334 (2010)
82. Moretti, A., Caron, L., Nakano, A., Lam, J.T., Bernshausen, A., Chen, Y., Qyang, Y., Bu, L., Sasaki, M., Martin-Puig, S., Sun, Y., Evans, S.M., Laugwitz, K.L., Chien, K.R.: Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127(6), 1151–1165 (2006)
83. Domian, I.J., Chiravuri, M., van der Meer, P., Feinberg, A.W., Shi, X., Shao, Y., Wu, S.M., Parker, K.K., Chien, K.R.: Generation of functional ventricular heart muscle from mouse ventricular progenitor cells. Science 326(5951), 426–429 (2009)
84. Knoll, R., Kostin, S., Klede, S., Savvatis, K., Klinge, L., Stehle, I., Gunkel, S., Kotter, S., Babicz, K., Sohns, M., Miocic, S., Didie, M., Knoll, G., Zimmermann, W.H., Thelen, P., Bickeboller, H., Maier, L.S., Schaper, W., Schaper, J., Kraft, T., Tschope, C., Linke, W.A., Chien, K.R.: A common mlp (muscle lim protein) variant is associated with cardiomyopathy. Circ. Res. 106(4), 695–704 (2010)
85. Wehrens, X.H., Lehnart, S.E., Huang, F., Vest, J.A., Reiken, S.R., Mohler, P.J., Sun, J., Guatimosim, S., Song, L.S., Rosemblit, N., D’Armiento, J.M., Napolitano, C., Memmi, M., Priori, S.G., Lederer, W.J., Marks, A.R.: Fkbp12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell 113(7), 829–840 (2003)
86. El-Armouche, A., Rau, T., Zolk, O., Ditz, D., Pamminger, T., Zimmermann, W.H., Jackel, E., Harding, S.E., Boknik, P., Neumann, J., Eschenhagen, T.: Evidence for protein phosphatase inhibitor-1 playing an amplifier role in beta-adrenergic signaling in cardiac myocytes. FASEB J. 17(3), 437–439 (2003)
87. El-Armouche, A., Singh, J., Naito, H., Wittkopper, K., Didie, M., Laatsch, A., Zimmermann, W.H., Eschenhagen, T.: Adenovirus-delivered short hairpin rna targeting pkcalpha improves contractile function in reconstituted heart tissue. J. Mol. Cell Cardiol. 43(3), 371–376 (2007)
88. Carvajal-Vergara, X., Sevilla, A., D’Souza, S.L., Ang, Y.S., Schaniel, C., Lee, D.F., Yang, L., Kaplan, A.D., Adler, E.D., Rozov, R., Ge, Y., Cohen, N., Edelmann, L.J., Chang, B., Waghray, A., Su, J., Pardo, S., Lichtenbelt, K.D., Tartaglia, M., Gelb, B.D., Lemischka, I.R.: Patient-specific induced pluripotent stem-cell-derived models of leopard syndrome. Nature 465(7299), 808–812 (2010)
89. Finlayson, K., Witchel, H.J., McCulloch, J., Sharkey, J.: Acquired qt interval prolongation and herg: Implications for drug discovery and development. Eur. J. Pharmacol. 500(1–3), 129–142 (2004)
90. Force, T., Krause, D.S., Van Etten, R.A.: Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition. Nat. Rev. Cancer 7(5), 332–344 (2007)
91. Zimmermann, W.H., Kehat, I., Boy, O., Gepstein, A., Neuhuber, W.L., Gepstein, L.: Three-dimensional culture induces advanced differentiation of primary rat and human embryonic stem cell derived cardiomyocytes: Implications for cardiac tissue engineering. In: Scientific Sessions of the American Heart Association, 2003. Circulation, pp IV-243 Abtract
92. Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S., Jones, J.M.: Embryonic stem cell lines derived from human blastocysts. Science 282(5391), 1145–1147 (1998)
93. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., Yamanaka, S.: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5), 861–872 (2007)
94. Kehat, I., Kenyagin-Karsenti, D., Snir, M., Segev, H., Amit, M., Gepstein, A., Livne, E., Binah, O., Itskovitz-Eldor, J., Gepstein, L.: Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 108(3), 407–414 (2001)
95. Zwi, L., Caspi, O., Arbel, G., Huber, I., Gepstein, A., Park, I.H., Gepstein, L.: Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 120(15), 1513–1523 (2009)
96. Hansen, A., Eder, A., Bonstrup, M., Flato, M., Mewe, M., Schaaf, S., Aksehirlioglu, B., Schworer, A., Uebeler, J., Eschenhagen, T.: Development of a drug screening platform based on engineered heart tissue. Circ Res
97. Jonsson, M.K., Duker, G., Tropp, C., Andersson, B., Sartipy, P., Vos, M.A., van Veen, T.A.: Quantified proarrhythmic potential of selected human embryonic stem cell-derived cardiomyocytes. Stem Cell Res. 4(3), 189–200 (2010)
98. Caspi, O., Itzhaki, I., Kehat, I., Gepstein, A., Arbel, G., Huber, I., Satin, J., Gepstein, L.: In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes. Stem Cells Dev. 18(1), 161–172 (2009)
99. Bergmann, O., Bhardwaj, R.D., Bernard, S., Zdunek, S., Barnabe-Heider, F., Walsh, S., Zupicich, J., Alkass, K., Buchholz, B.A., Druid, H., Jovinge, S., Frisen, J.: Evidence for cardiomyocyte renewal in humans. Science 324(5923), 98–102 (2009)
100. Sharples, L.D., Cafferty, F., Demitis, N., Freeman, C., Dyer, M., Banner, N., Birks, E.J., Khaghani, A., Large, S.R., Tsui, S., Caine, N., Buxton, M.: Evaluation of the clinical effectiveness of the ventricular assist device program in the United Kingdom (evad UK). J. Heart Lung Transplant. 26(1), 9–15 (2007)
101. Rose, E.A., Gelijns, A.C., Moskowitz, A.J., Heitjan, D.F., Stevenson, L.W., Dembitsky, W., Long, J.W., Ascheim, D.D., Tierney, A.R., Levitan, R.G., Watson, J.T., Meier, P., Ronan, N.S., Shapiro, P.A., Lazar, R.M., Miller, L.W., Gupta, L., Frazier, O.H., Desvigne-Nickens, P., Oz, M.C., Poirier, V.L.: Long-term mechanical left ventricular assistance for end-stage heart failure. N. Engl. J. Med. 345(20), 1435–1443 (2001)
102. Zimmermann, W.H., Cesnjevar, R.: Cardiac tissue engineering: Implications for pediatric heart surgery. Pediatr. Cardiol. 30(5), 716–723 (2009)
103. Oz, M.C., Gelijns, A.C., Miller, L., Wang, C., Nickens, P., Arons, R., Aaronson, K., Richenbacher, W., van Meter, C., Nelson, K., Weinberg, A., Watson, J., Rose, E.A., Moskowitz, A.J.: Left ventricular assist devices as permanent heart failure therapy: the price of progress. Ann. Surg. 238(4), 577–583 (2003). discussion 583–575
104. Gepstein, L.: Derivation and potential applications of human embryonic stem cells. Circ. Res. 91(10), 866–876 (2002)
105. Zandstra, P.W., Bauwens, C., Yin, T., Liu, Q., Schiller, H., Zweigerdt, R., Pasumarthi, K.B., Field, L.J.: Scalable production of embryonic stem cell-derived cardiomyocytes. Tissue Eng. 9(4), 767–778 (2003)
106. Kim, K., Lerou, P., Yabuuchi, A., Lengerke, C., Ng, K., West, J., Kirby, A., Daly, M.J., Daley, G.Q.: Histocompatible embryonic stem cells by parthenogenesis. Science 315(5811), 482–486 (2007)
107. Athanasuleas, C.L., Stanley Jr., A.W., Buckberg, G.D., Dor, V., DiDonato, M., Blackstone, E.H.: Surgical anterior ventricular endocardial restoration (saver) in the dilated remodeled ventricle after anterior myocardial infarction. Restore group. Reconstructive endoventricular surgery, returning torsion original radius elliptical shape to the lv. J. Am. Coll. Cardiol. 37(5), 1199–1209 (2001)
108. Matsubayashi, K., Fedak, P.W., Mickle, D.A., Weisel, R.D., Ozawa, T., Li, R.K.: Improved left ventricular aneurysm repair with bioengineered vascular smooth muscle grafts. Circulation 108(Suppl 1), II219–II225 (2003)
109. Ozawa, T., Mickle, D.A., Weisel, R.D., Matsubayashi, K., Fujii, T., Fedak, P.W., Koyama, N., Ikada, Y., Li, R.K.: Tissue-engineered grafts matured in the right ventricular outflow tract. Cell Transplant. 13(2), 169–177 (2004)
110. Bredin, F., Franco-Cereceda, A., Midterm results of passive containment surgery using the acorn cor cap cardiac support device in dilated cardiomyopathy. J Card Surg 25(1):107–112 (2010)
111. Walsh, R.G.: Design and features of the acorn corcap cardiac support device: The concept of passive mechanical diastolic support. Heart Fail Rev. 10(2), 101–107 (2005)
112. Yildirim, Y., Naito, H., Didie, M., Karikkineth, B.C., Biermann, D., Eschenhagen, T., Zimmermann, W.H.: Development of a biological ventricular assist device: Preliminary data from a small animal model. Circulation 116(11 Suppl), I16–I23 (2007)
113. Chachques, J.C., Trainini, J.C., Lago, N., Masoli, O.H., Barisani, J.L., Cortes-Morichetti, M., Schussler, O., Carpentier, A.: Myocardial assistance by grafting a new bioartificial upgraded myocardium (magnum clinical trial): one year follow-up. Cell Transplant. 16(9), 927–934 (2007)
114. Archer, R., Williams, D.J.: Why tissue engineering needs process engineering. Nat. Biotechnol. 23(11), 1353–1355 (2005)